Paysign financials
$12.85+1.02%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 | FY20 Dec 31 | FY19 Dec 31 |
|---|---|---|---|---|---|---|---|
| Revenue | $82.0M | $58.4M | $47.3M | $38.0M | $29.5M | $24.1M | $34.7M |
| Gross profit | $48.7M | $32.2M | $24.1M | $21.0M | $14.7M | $9.3M | $19.2M |
| Gross margin | 59.4% | 55.1% | 51.1% | 55.1% | 49.9% | 38.6% | 55.5% |
| Operating income | $7.4M | $1.0M | -$167.3K | $344.3K | -$2.7M | -$8.3M | $6.1M |
| Net income | $7.6M | $3.8M | $6.5M | $1.0M | -$2.7M | -$9.1M | $7.5M |
| Net margin | 9.2% | 6.5% | 13.7% | 2.7% | −9.2% | −37.9% | 21.5% |
| Diluted EPS | $0.13 | $0.07 | $0.12 | $0.02 | $-0.05 | $-0.19 | $0.14 |
| EBITDA | $15.7M | $7.0M | $3.9M | $3.3M | -$241.5K | -$5.8M | $7.6M |
| Operating cash flow | $52.5M | $22.9M | $27.6M | $25.3M | $15.2M | $13.8M | $16.7M |
| Free cash flow | $51.2M | $22.5M | $27.4M | $25.2M | $14.9M | $12.4M | $16.2M |
| Diluted shares | 59.6M | 55.6M | 54.2M | 52.9M | 51.0M | 49.3M | 54.6M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $21.1M | $10.8M | $17.0M | $9.7M | $7.4M | $7.8M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | — | — |
| Total debt | $8.0M | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total assets | $276.3M | $179.0M | $146.6M | $108.2M | $84.1M | $67.8M |
| Total liabilities | $227.8M | $148.6M | $122.1M | $92.0M | $71.1M | $54.6M |
| Shareholders' equity | $48.5M | $30.4M | $24.5M | $16.3M | $13.0M | $13.2M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology